WuXi AppTec Co., Ltd. (HKG:2359)

Market Cap	160.66B
Revenue (ttm)	40.35B
Net Income (ttm)	10.06B
Shares Out	n/a
EPS (ttm)	2.90
PE Ratio	15.98
Forward PE	n/a
Dividend	1.09 (2.09%)
Ex-Dividend Date	May 8, 2025

Volume	3,660,443
Average Volume	10,257,381
Open	51.10
Previous Close	51.10
Day's Range	50.80 - 52.00
52-Week Range	27.50 - 76.00
Beta	0.87
RSI	36.22
Earnings Date	Apr 28, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2359

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY